| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 02/14/2007 | EP1750671A1 Liposomal assembly for therapeutic and/or diagnostic use |
| 02/14/2007 | CN1299695C Liquid embolism agent for intracranial aneurysm and its preparing process |
| 02/13/2007 | US7176345 Rodent model comprising genes coding hypoxia inducible factor (HIF) for detection of hypoxic tissue |
| 02/13/2007 | US7176181 Enhancement or inhibition of the interactions of galectin-8 and galectin-8-like proteins with other extracellular matrix proteins or cell surface receptors; the use of modulators of cell adhesion; antitumor, -carcinogenic, -metastasis agents |
| 02/13/2007 | US7175831 Useful for optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo |
| 02/13/2007 | US7175830 Labelling with radioactive materials |
| 02/13/2007 | US7175829 Contrast-enhanced diagnostic imaging method for monitoring interventional therapies |
| 02/13/2007 | US7175430 Support materials and imaging method for intraoral diagnostic purposes |
| 02/13/2007 | CA2123241C Nucleosides and oligonucleotides having 2'ether groups |
| 02/08/2007 | WO2006079071A3 Methods and compositions related to tr4 |
| 02/08/2007 | US20070032426 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 02/08/2007 | US20070031484 Immunoliposomes that optimize internationalization into target cells |
| 02/08/2007 | US20070031389 Using cardiac graft to treat and prevent scar tissue on heart; tissue engineering and regenerative medicine |
| 02/08/2007 | US20070031339 Contrast agents |
| 02/08/2007 | US20070031338 Embolized cryoablation for treatment of tumors |
| 02/08/2007 | US20070031337 Nanoparticle enhanced proton computed tomography and proton therapy |
| 02/08/2007 | US20070031336 3H-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof |
| 02/08/2007 | US20070031335 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 02/08/2007 | DE102005024625B3 Stent zur Positionierung in einer Körperröhre Stent for positioning in a body tube |
| 02/07/2007 | EP1749026A1 Labelled adrenomedullin derivatives and their use for imaging and therapy |
| 02/07/2007 | EP1748992A1 Trimeric macrocyclic substituted aminoisophthalate halophenyl derivatives |
| 02/07/2007 | EP1748977A1 Method for producing 1-hydroxymethyl-1,3,5-triazapentane, trihydrochloride |
| 02/07/2007 | EP1748796A2 Multilayered nanomedicine delivery system and method |
| 02/07/2007 | EP0971748B1 Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy |
| 02/07/2007 | CN2865604Y Solid phase dust-like dynamic inhalation contamination experimental device |
| 02/07/2007 | CN1910192A Metal complexes having vitamin B12 as a ligand |
| 02/07/2007 | CN1909931A Ultrasound contrast agents for molecular imaging |
| 02/07/2007 | CN1909920A Method for the delivery of sustained release agents |
| 02/07/2007 | CN1909779A Method for sifting nerve active compound and related nerve plasticity |
| 02/07/2007 | CN1907498A Rapid preparing method of insulin opposing model |
| 02/07/2007 | CN1907497A Method for study and test of cardiovascular function |
| 02/07/2007 | CN1907496A Hematological test method for studying anemia and hematopoiesis model |
| 02/07/2007 | CN1298844C MSH5 ablated mice and use therefor |
| 02/07/2007 | CN1298400C Medical care device of ultrasound microbubble contrast media to form embolism in capillary vessel |
| 02/07/2007 | CN1298390C Smulaneous imaging of cardiac perfusion and vitronection receptor targeted imaging agent |
| 02/06/2007 | US7172751 D-amino acid peptides |
| 02/06/2007 | US7172750 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/06/2007 | CA2287262C Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy |
| 02/06/2007 | CA2207077C Cross-linked microparticles and their use as therapeutic vehicles |
| 02/01/2007 | WO2007014322A2 Nanomagnetic detector array for biomolecular recognition |
| 02/01/2007 | WO2007013877A2 Signal peptide-semiconductor nanocrystal conjugates |
| 02/01/2007 | WO2007013409A1 Oral preparation useful in measuring capacity to metabolize pyridine |
| 02/01/2007 | WO2006131292A3 Method for dissolution of gases with short-lived physical properties in a liquid |
| 02/01/2007 | WO2006114286A3 Production of albumin-fluorescein conjugates for use in intraoperative diagnosis |
| 02/01/2007 | WO2006032441A3 Stoichiometrically defined dye-labeled substances for measuring glomerular filtration rate |
| 02/01/2007 | WO2005115105A3 Self-immolative magnetic resonance imaging contrast agents sensitive to beta-glucuronidase |
| 02/01/2007 | WO2005112919A3 Self-immolative linkers and drug conjugates |
| 02/01/2007 | WO2005077082A3 INHIBITING CAV3 ISOFORMS AND THE δ25B SPLICE VARIENTS FOR THE DIAGNOSIS AND TREATMENT OF CANCER |
| 02/01/2007 | US20070027129 Taxane, magnetic moiety and covalent binder for production of magnetic antimitotic agent with higher toxicity to cancer cells than normal cells |
| 02/01/2007 | US20070025918 Magnetic resonance imaging (MRI) agents: water soluble carbon-13 enriched fullerene and carbon nanotubes for use with dynamic nuclear polarization |
| 02/01/2007 | US20070025917 Optical imaging based on locally activated bioluminescence |
| 02/01/2007 | US20070025916 Porcine Helicobacter infection |
| 02/01/2007 | CA2616788A1 Oral preparation useful in measuring capacity to metabolize pyridine |
| 01/31/2007 | EP1747277A1 Method for gene delivery to neuronal cells |
| 01/31/2007 | EP1747026A1 Biomolecular contrast agents for therapy control in radiation therapy with proton or ion beams |
| 01/31/2007 | EP1747025A2 Method for diagnosing infectious diseases |
| 01/31/2007 | EP1747021A2 Self-immolative linkers and drug conjugates |
| 01/31/2007 | EP1747018A2 Method for the production of carbon nanotubes that are ferromagnetically filled in part and carry biomolecules, and use thereof in diagnosis and therapy |
| 01/31/2007 | EP1746928A1 Optical sensor for in vivo detection of analyte |
| 01/31/2007 | CN1905904A Novel imaging agents comprising caspase-3 inhibitors |
| 01/31/2007 | CN1903374A Application of colon bacillus for preparing medicine for diagnosis and treatment of tumor |
| 01/30/2007 | US7169753 Such as magnesium-containing tetrahydroporphyrin for use in photodynamic therapy, tumor diagnosis, bactericides, and viricides; transesterification |
| 01/30/2007 | US7169572 Assays for determining anticoagulant cofactor activity |
| 01/30/2007 | CA2210751C Anti-cd6 monoclonal antibodies and their uses |
| 01/25/2007 | WO2007011834A2 Compounds and method for the diagnosis and treatment of amyloid associated diseases |
| 01/25/2007 | WO2007010128A1 Target vector with activable imaging function |
| 01/25/2007 | WO2007009638A2 Complexes containing perfluoroalkyl, method for the production and use thereof |
| 01/25/2007 | WO2006036476A3 Methods of detecting myocardial ischemia and myocardial infarction |
| 01/25/2007 | WO2005065079A3 Medical implants and fibrosis-inducing agents |
| 01/25/2007 | US20070020252 Modified protease inhibitors |
| 01/25/2007 | US20070020185 Diagnostic imaging contrast agents with extended blood retention |
| 01/25/2007 | US20070020184 Diagnostic imaging contrast agents with extended blood retention |
| 01/25/2007 | US20070020183 Perfluoroalkyl-containing complexes, process for their production as well as their use |
| 01/25/2007 | US20070020182 Quaternary nitrogen heterocyclic boronic acid-containing compounds sensitive to glucose and fructose; contact lens; radiometers; kits; ophthalmic sensors |
| 01/25/2007 | US20070020181 Non-invasive measurement of analytes |
| 01/25/2007 | US20070020180 Method for determining the impact of a multicomponent natural product mixture on the biological profile of a disease within a group of living systems and the developement and quality control of natural product based medicine |
| 01/25/2007 | US20070020177 Radiometal complex compositions |
| 01/25/2007 | US20070020176 Contrast agent |
| 01/25/2007 | CA2615744A1 Plexin d1 as a target for tumor diagnosis and therapy |
| 01/25/2007 | CA2615443A1 Perfluoroalkyl-containing complexes, process for their production as well as their use |
| 01/25/2007 | CA2615434A1 Perfluoroalkyl-containing complexes, process for their production as well as their use |
| 01/24/2007 | EP1746610A2 Magnetic nanoparticles of noble metals |
| 01/24/2007 | EP1745739A2 Optical imaging of rheumatoid arthritis |
| 01/24/2007 | EP1744789A1 Activatable particles, preparations and uses |
| 01/24/2007 | EP1744664A2 Percutaneous chemical sensor based on fluorescence resonant energy transfer (fret) |
| 01/24/2007 | EP1744620A2 Novel gene disruptions, compositions and methods relating thereto |
| 01/24/2007 | EP1390405B1 Preparation of cholecystokinin agonists and antagonists and their therapeutic and diagnostic use |
| 01/24/2007 | EP1257285B1 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 01/24/2007 | EP0996470B1 Method for enhancing the echogenicity and decreasing the attenuation of microencapsulated gases |
| 01/24/2007 | CN1901941A Conjugates of angiotensin ii and an imaging moiety |
| 01/24/2007 | CN1901940A Polymeric marker with high radiopacity for use in medical devices |
| 01/24/2007 | CN1901936A Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 01/24/2007 | CN1901894A Inhibitor imaging agents |
| 01/24/2007 | CN1899615A Preparation for the prophylaxis of restenose |
| 01/24/2007 | CN1899614A Preparation for the prophylaxis of restenose |
| 01/24/2007 | CN1899602A RanBPM important function in nervous system |
| 01/23/2007 | US7166762 Method of constructing heart failure model animal |
| 01/23/2007 | US7166695 Affinity markers for human serum albumin |
| 01/23/2007 | US7166584 Administering glyburide to intestinal lumen of animals; inhibits transport of cholesterol to the bloodstream; modulates the activity of ATP- binding cassette (ABC1) protein |
| 01/23/2007 | US7166570 Treating varicose or veins by injecting a composition silk made of polyalkylene oxide-polyester block copolymer into the lumen of a vein; anchoring implantable medical devices into or onto biological tissue |